279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion
12 clinical trials,   23 drugs   (DrugBank: 9 drugs),   3 drug target genes,   103 drug target pathways
Searched query = "Huge venous malformation with cervical, oral and pharyngeal diffuse lesion", "Huge venous malformation", "Venous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01347294 (ClinicalTrials.gov) | August 2011 | 11/4/2011 | Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations | Compare the Effect of Bleomycin and Tetradecyl Sodium Sulphate in the Treatment of Venous Malformations | Venous Malformation | Drug: Bleomycin;Drug: Fibrovein;Drug: Bleomycin + Fibrovein | Oslo University Hospital | NULL | Recruiting | 12 Years | 80 Years | All | 126 | Phase 4 | Norway |